UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

The "ComPAS Trial" combined treatment model for acute malnutrition: study protocol for the economic evaluation

Lelijveld, N; Bailey, J; Mayberry, A; Trenouth, L; N'Diaye, DS; Haghparast-Bidgoli, H; Puett, C; (2018) The "ComPAS Trial" combined treatment model for acute malnutrition: study protocol for the economic evaluation. Trials , 19 (1) , Article 252. 10.1186/s13063-018-2594-7. Green open access

[thumbnail of Haghparast-Bidgoli_The ComPAS Trial combined treatment model for acute malnutrition. Study protocol for the economic evaluation_VoR.pdf]
Preview
Text
Haghparast-Bidgoli_The ComPAS Trial combined treatment model for acute malnutrition. Study protocol for the economic evaluation_VoR.pdf - Published Version

Download (529kB) | Preview

Abstract

BACKGROUND: Acute malnutrition is currently divided into severe (SAM) and moderate (MAM) based on level of wasting. SAM and MAM currently have separate treatment protocols and products, managed by separate international agencies. For SAM, the dose of treatment is allocated by the child’s weight. A combined and simplified protocol for SAM and MAM, with a standardised dose of ready-to-use therapeutic food (RUTF), is being trialled for non-inferior recovery rates and may be more cost-effective than the current standard protocols for treating SAM and MAM. METHOD: This is the protocol for the economic evaluation of the ComPAS trial, a cluster-randomised controlled, non-inferiority trial that compares a novel combined protocol for treating uncomplicated acute malnutrition compared to the current standard protocol in South Sudan and Kenya. We will calculate the total economic costs of both protocols from a societal perspective, using accounting data, interviews and survey questionnaires. The incremental cost of implementing the combined protocol will be estimated, and all costs and outcomes will be presented as a cost-consequence analysis. Incremental cost-effectiveness ratio will be calculated for primary and secondary outcome, if statistically significant. DISCUSSION: We hypothesise that implementing the combined protocol will be cost-effective due to streamlined logistics at clinic level, reduced length of treatment, especially for MAM, and reduced dosages of RUTF. The findings of this economic evaluation will be important for policymakers, especially given the hypothesised non-inferiority of the main health outcomes. The publication of this protocol aims to improve rigour of conduct and transparency of data collection and analysis. It is also intended to promote inclusion of economic evaluation in other nutrition intervention studies, especially for MAM, and improve comparability with other studies. TRIAL REGISTRATION: ISRCTN 30393230, date: 16/03/2017.

Type: Article
Title: The "ComPAS Trial" combined treatment model for acute malnutrition: study protocol for the economic evaluation
Open access status: An open access version is available from UCL Discovery
DOI: 10.1186/s13063-018-2594-7
Publisher version: https://doi.org/10.1186/s13063-018-2594-7
Additional information: © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).
Keywords: Cost-effectiveness, Severe acute malnutrition, Moderate acute malnutrition, ommunity management of acute malnutrition, Cost-consequence analysis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10050868
Downloads since deposit
4,940Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item